Return to Work Among Young Adult Survivors of Allogeneic Hematopoietic Cell Transplantation in the United States

被引:15
|
作者
Bhatt, Neel S. [1 ]
Brazauskas, Ruta [2 ,3 ]
Salit, Rachel B. [1 ]
Syrjala, Karen [1 ]
Bo-Subait, Stephanie [4 ]
Tecca, Heather [2 ]
Badawy, Sherif M. [5 ,6 ]
Baker, K. Scott [1 ]
Beitinjaneh, Amer [7 ]
Bejanyan, Nelli [8 ]
Byrne, Michael [9 ]
Dias, Ajoy [10 ]
Farhadfar, Nosha [11 ]
Freytes, Cesar O. [12 ]
Ganguly, Siddhartha [13 ]
Hashmi, Shahrukh [14 ,15 ]
Hayashi, Robert J. [16 ]
Hong, Sanghee [17 ]
Inamoto, Yoshihiro [18 ]
Jamani, Kareem [19 ]
Kasow, Kimberly A. [20 ]
Khera, Nandita [21 ]
Krem, Maxwell M. [22 ]
Lazarus, Hillard M. [23 ]
Lee, Catherine J. [24 ]
Lee, Stephanie [1 ,2 ]
Majhail, Navneet S. [17 ]
Malone, Adriana K. [25 ]
Marks, David, I [26 ]
Mau, Lih-Wen [4 ]
Mayo, Samantha J. [27 ]
Muffly, Lori S. [28 ]
Nathan, Sunita [29 ]
Nishihori, Taiga [8 ]
Page, Kristin M. [30 ]
Preussler, Jaime [4 ]
Rangarajan, Hemalatha G. [31 ]
Rotz, Seth J. [32 ]
Salooja, Nina [33 ]
Savani, Bipin N. [34 ]
Schears, Raquel [35 ]
Schechter-Finkelstein, Tal [36 ]
Schiller, Gary [37 ]
Shah, Ami J. [38 ]
Sharma, Akshay [39 ]
Wang, Trent [7 ]
Wirk, Baldeep [40 ]
Battiwalla, Minoo [41 ]
Schoemans, Helene [42 ,43 ]
Hamilton, Betty [17 ]
机构
[1] Fred Hutchinson Canc Res Ctr, Clin Res Div, 1100 Fairview Ave N,D5-390, Seattle, WA 98109 USA
[2] Med Coll Wisconsin, Dept Med, Ctr Int Blood & Marrow Transplant Res, Milwaukee, WI 53226 USA
[3] Med Coll Wisconsin, Inst Hlth & Equ, Div Biostat, Milwaukee, WI 53226 USA
[4] Ctr Int Blood & Marrow Transplant Res, Natl Marrow Donor Program Be Match, Minneapolis, MN USA
[5] Ann & Robert H Lurie Childrens Hosp Chicago, Div Hematol Oncol & Stem Cell Transplant, Chicago, IL 60611 USA
[6] Northwestern Univ, Dept Pediat, Feinberg Sch Med, Chicago, IL 60611 USA
[7] Univ Miami, Div Transplantat & Cellular Therapy, Miami, FL USA
[8] H Lee Moffitt Canc Ctr & Res Inst, Dept Blood & Marrow Transplant & Cellular Immunot, Tampa, FL USA
[9] Vanderbilt Univ, Med Ctr, Nashville, TN USA
[10] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[11] Univ Florida, Coll Med, Div Hematol Oncol, Gainesville, FL USA
[12] Texas Transplant Inst, San Antonio, TX USA
[13] Univ Kansas Hlth Syst, Div Hematol Malignancy & Cellular Therapeut, Kansas City, KS USA
[14] Mayo Clin, Dept Internal Med, Rochester, MN USA
[15] Sheikh Shakhbout Med City, Dept Med, Abu Dhabi, U Arab Emirates
[16] Washington Univ, Sch Med, Dept Pediat, Div Pediat Hematol Oncol, St Louis, MO 63110 USA
[17] Cleveland Clin, Blood & Marrow Transplant Program, Taussig Canc Inst, Cleveland, OH 44106 USA
[18] Natl Canc Ctr, Div Hematopoiet Stem Cell Transplantat, Tokyo, Japan
[19] Univ Calgary, Tom Baker Canc Ctr, Calgary, AB, Canada
[20] Univ N Carolina, Chapel Hill, NC USA
[21] Mayo Clin, Dept Hematol Oncol, Phoenix, AZ USA
[22] Univ Kentucky, Coll Med, Markey Canc Ctr, Lexington, KY USA
[23] Case Western Reserve Univ, Univ Hosp Cleveland Med Ctr, Cleveland, OH 44106 USA
[24] Univ Utah, Utah Blood & Marrow Transplant Program, Huntsman Canc Inst, Salt Lake City, UT USA
[25] Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA
[26] Univ Hosp Bristol NHS Trust, Adult Bone Marrow Transplant, Bristol, Avon, England
[27] Univ Toronto, Lawrence S Bloomberg Fac Nursing, Toronto, ON, Canada
[28] Stanford Univ, Div Blood & Marrow Transplantat, Stanford, CA 94305 USA
[29] Rush Univ, Sect Bone Marrow Transplant & Cell Therapy, Med Ctr, Chicago, IL USA
[30] Duke Univ, Div Pediat Blood & Marrow Transplantat, Med Ctr, Durham, NC USA
[31] Nationwide Childrens Hosp, Dept Pediat Hematol Oncol Blood & Marrow Transpla, Columbus, OH USA
[32] Cleveland Clin, Dept Pediat Hematol Oncol & Blood & Marrow Transp, Childrens Hosp, Cleveland, OH USA
[33] Imperial Coll London, London, England
[34] Vanderbilt Univ, Med Ctr, Dept Med, Div Hematol Oncol, Nashville, TN USA
[35] Univ Cent Florida, Dept Emergency Med, Orlando, FL 32816 USA
[36] Hosp Sick Children, Toronto, ON, Canada
[37] Univ Calif Los Angeles, David Geffen Sch Med, Hematol Malignancy Stem Cell Transplant Program, Los Angeles, CA 90095 USA
[38] Stanford Sch Med, Lucille Packard Childrens Hosp, Div Stem Cell Transplantat & Regenerat Med, Palo Alto, CA USA
[39] St Jude Childrens Res Hosp, Dept Bone Marrow Transplantat & Cellular Therapy, 332 N Lauderdale St, Memphis, TN 38105 USA
[40] Penn State Canc Inst, Bone Marrow Transplant Program, Hershey, PA USA
[41] Sarah Cannon Blood Canc Network, Nashville, TN USA
[42] Univ Hosp Leuven, Dept Hematol, Leuven, Belgium
[43] Katholieke Univ Leuven, Leuven, Belgium
[44] Childrens Hosp Orange Cty, Div Pediat Hematol, Orange, CA USA
来源
TRANSPLANTATION AND CELLULAR THERAPY | 2021年 / 27卷 / 08期
关键词
Hematopoietic cell transplantation; Return to work; Quality of life; Young adult; QUALITY-OF-LIFE; CHILDHOOD-CANCER-SURVIVOR; VERSUS-HOST-DISEASE; ADOLESCENT; RECIPIENTS; HEALTH; MARROW; EMPLOYMENT; EDUCATION; RECOVERY;
D O I
10.1016/j.jtct.2021.04.013
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Young adult (YA) survivors of allogeneic hematopoietic cell transplantation (HCT) are at risk for late psychosocial challenges, including the inability to return to work post-HCT. Work-related outcomes in this population remain understudied, however. We conducted this study to assess the post-HCT work status of survivors of allogeneic HCT who underwent HCT as YAs and to analyze the patient-, disease-, and HCT-related factors associated with their work status at 1 year post-HCT. Using Center for International Blood and Marrow Transplant Research data, we evaluated the post-HCT work status (full-time, part-time work, unemployed, or medical disability) of 1365 YA HCT survivors who underwent HCT between 2008 and 2015. Percentages of work status categories were reported at 4 time points: 6 months, 1 year, 2 years, and 3 years post-HCT. Percentages of post-HCT work status categories at the 1-year time point were also described in relation to survivors' pre-HCT work status categories. Factors associated with 1-year post-HCT work status (full-time or part-time work) were examined using logistic regression. From 6 months to 3 years post-HCT, the percentage of survivors working full-time increased from 18.3% to 50.7% and the percentage working part-time increased from 6.9% to 10.5%. Of patients in full-time work pre-HCT, 50% were unemployed or on medical disability at 1 year post-HCT. Female sex (odds ratio [OR], 0.55; 95% confidence interval [CI], 0.40 to 0.77), HCT Comorbidity Index score >= 3 (OR, 0.57; 95% CI, 0.39 to 0.82), pre-HCT unemployment (OR, 0.37; 95% CI, 0.24 to 0.56), medical disability (OR, 0.44; 95% CI, 0.28 to 0.70), development of grade III-IV acute graft-versus-host disease (OR, 0.52; 95% CI, 0.34 to 0.80), and relapse within 1 year post-HCT (OR, 0.34; 95% CI, 0.21 to 0.56) were associated with a lower likelihood of employment at 1 year post-HCT. Compared with myeloablative conditioning (MAC) with total body irradiation (TBI), MAC without TBI (OR, 1.71; 95% CI, 1.16 to 2.53) was associated with a greater likelihood of employment at 1 year post-HCT. Graduate school-level education (OR, 2.47; 95% CI, 1.49 to 4.10) was also associated with a greater likelihood of employment at 1 year post-HCT. Although the work status among YA HCT survivors continued to improve over time, a substantial subset became or remained unemployed or on medical disability. These findings underscore the need for effective interventions to support return to work in this population. (C) 2021 The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:679.e1 / 679.e8
页数:8
相关论文
共 50 条
  • [31] Food insecurity among adult cancer survivors in the United States
    Trego, M. L.
    Baba, Z. M.
    DiSantis, K., I
    Longacre, M. L.
    JOURNAL OF CANCER SURVIVORSHIP, 2019, 13 (04) : 641 - 652
  • [32] Community health status and outcomes after allogeneic hematopoietic cell transplantation in the United States
    Hong, Sanghee
    Brazauskas, Ruta
    Hebert, Kyle M.
    Ganguly, Siddhartha
    Abdel-Azim, Hisham
    Diaz, Miguel Angel
    Beattie, Sara
    Ciurea, Stefan O.
    Szwajcer, David
    Badawy, Sherif M.
    Gratwohl, Alois A.
    LeMaistre, Charles
    Aljurf, Mahmoud D. S. M.
    Olsson, Richard F.
    Bhatt, Neel S.
    Farhadfar, Nosha
    Yared, Jean A.
    Yoshimi, Ayami
    Seo, Sachiko
    Gergis, Usama
    Beitinjaneh, Amer M.
    Sharma, Akshay
    Lazarus, Hillard
    Law, Jason
    Ulrickson, Matthew
    Hashem, Hasan
    Schoemans, Helene
    Cerny, Jan
    Rizzieri, David
    Savani, Bipin N.
    Kamble, Rammurti T.
    Shaw, Bronwen E.
    Khera, Nandita
    Wood, William A.
    Hashmi, Shahrukh
    Hahn, Theresa
    Lee, Stephanie J.
    Rizzo, J. Douglas
    Majhail, Navneet S.
    Saber, Wael
    CANCER, 2021, 127 (04) : 609 - 618
  • [33] Sustainable return to work among breast cancer survivors
    Ruiz de Azua, Garazi
    Kousignian, Isabelle
    Vaz-Luis, Ines
    Di Meglio, Antonio
    Caumette, Elsa
    Havas, Julie
    Martin, Elise
    Martin, Anne-Laure
    Querel, Ophelie
    Vanlemmens, Laurence
    Pistilli, Barbara
    Coutant, Charles
    Cottu, Paul Henri
    Merimeche, Asma Dhaini
    Lerebours, Florence
    Tredan, Olivier
    Jouannaud, Christelle
    Levy, Christelle
    Dumas, Agnes
    Menvielle, Gwenn
    CANCER MEDICINE, 2023, 12 (18): : 19091 - 19101
  • [34] Return to work and work-related disability among AML survivors
    Samadi, Osai
    Breunis, Henriette
    Sandoval, Joanna
    Akilan, Kosalan
    Timilshina, Narhari
    Alibhai, Shabbir M. H.
    ANNALS OF HEMATOLOGY, 2017, 96 (10) : 1625 - 1633
  • [35] Work Outcomes and Medical Costs Among Singaporean Adolescent and Young Adult Cancer Survivors
    Tan, Chia Jie
    Ng, Kim Yoke Jennifer
    Goh, Wei Lin
    Poon, Eileen
    Chan, Raymond Javan
    Chew, Lita
    Farid, Mohamad
    Chan, Alexandre
    JOURNAL OF ADOLESCENT AND YOUNG ADULT ONCOLOGY, 2023, 12 (03) : 416 - 424
  • [36] Female Long-Term Survivors After Allogeneic Hematopoietic Stem Cell Transplantation: Evaluation and Management
    Shanis, Dana
    Merideth, Melissa
    Pulanic, Tajana Klepac
    Savani, Bipin N.
    Battiwalla, Minoo
    Stratton, Pamela
    SEMINARS IN HEMATOLOGY, 2012, 49 (01) : 83 - 93
  • [37] Prevalence of Hematopoietic Cell Transplant Survivors in the United States
    Majhail, Navneet S.
    Tao, Li
    Bredeson, Christopher
    Davies, Stella
    Dehn, Jason
    Gajewski, James L.
    Hahn, Theresa
    Jakubowski, Ann
    Joffe, Steven
    Lazarus, Hillard M.
    Parsons, Susan K.
    Robien, Kim
    Lee, Stephanie J.
    Kuntz, Karen M.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (10) : 1498 - 1501
  • [38] Population Pharmacokinetics of Unbound Mycophenolic Acid in Pediatric and Young Adult Patients Undergoing Allogeneic Hematopoietic Cell Transplantation
    Kim, Hyewon
    Long-Boyle, Janel
    Rydholm, Nancy
    Orchard, Paul J.
    Tolar, Jakub
    Smith, Angela R.
    Jacobson, Pamala
    Brundage, Richard
    JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 52 (11) : 1665 - 1675
  • [39] Decisional Regret in Long-Term Australian Allogeneic Hematopoietic Stem Cell Transplantation Survivors: A Cross-Sectional Survey
    McErlean, Gemma
    Tapp, Caley
    Brice, Lisa
    Pradhan, Anisha
    Gilroy, Nicole
    Kabir, Masura
    Greenwood, Matt
    Larsen, Stephen R.
    Moore, John
    Gottlieb, David
    Hertzberg, Mark
    Brown, Louisa
    Hogg, Megan
    Huang, Gillian
    Ward, Christopher
    Kerridge, Ian
    CLINICAL NURSING RESEARCH, 2023, 32 (08) : 1134 - 1144
  • [40] Religious/Spiritual Struggle in Young Adult Hematopoietic Cell Transplant Survivors
    King, Stephen D. W.
    Fitchett, George
    Murphy, Patricia E.
    Rajaee, Geila
    Pargament, Kenneth I.
    Loggers, Elizabeth Trice
    Harrison, David A.
    Johnson, Rebecca H.
    JOURNAL OF ADOLESCENT AND YOUNG ADULT ONCOLOGY, 2018, 7 (02) : 210 - 216